MedTrace Logo

Gene Expression Profiles in Predicting Survival of Patients With Head and Neck Cancer

NCT00897052 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29

Last updated 2012-09-10

No results posted yet for this study

Summary

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict survival of patients with head and neck cancer.

PURPOSE: This laboratory study is assessing gene expression profiles in predicting survival of patients with head and neck cancer.

Conditions

Interventions

GENETIC

microarray analysis

Assay RNA obtained from archived formalin fixed paraffin embedded tissue samples

OTHER

laboratory biomarker analysis

The gene expression data will be linked to the clinical information in order to generate profile of recurrence and survival as a biomarker.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Vanderbilt-Ingram Cancer Center

    lead OTHER

Principal Investigators

  • Barbara Murphy, MD · Vanderbilt-Ingram Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-02-28
Primary Completion
2007-12-31
Completion
2007-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00897052 on ClinicalTrials.gov